EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Percutaneous Cryoablation of Metastatic Lesions from Colorectal Cancer: Efficacy and Feasibility with Survival and Cost-Effectiveness Observations

Hyun J Bang, Peter J Littrup, Brandt P Currier, Dylan J Goodrich, Minsig Choi, Lance K Heilbrun, Allen C Goodman

ISRN Minimally Invasive Surgery · 2012

DOI: 10.5402/2012/942364 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ISRN Minimally Invasive Surgery, 2012. Verfasst von Hyun J Bang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Wayne State University, Detroit, MI 48201, USA ; Department of Radiology, Wayne State University, 22473 Milner Street, St. Clair Shores, MI 48081, US…. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: NCI NIH HHS.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To assess feasibility, complications, local tumor recurrences, overall survival (OS) and estimates of cost-effectiveness for multi-site cryoablation (MCA) of oligo-metastatic colorectal cancer (mCRC) in a prospective study. Materials and Methods . 111 CT and/or US-guided percutaneous MCA procedures were performed on 151 tumors in 59 oligo mCRC patients. Mean patient age was 63 years (range 21–92 years), consisting of 29 males and 30 females. Tumor location was grouped according to common metastatic sites. Median OS was determined using the Kaplan-Meier. Estimates of MCA costs per LYG were compared to historical values for systemic therapies.

Results

A mean 1.9 MCAs per patient were performed with a median clinical follow-up of 12 months. Major complication and local recurrence rates were 8% (9/111) and 12% (18/151), respectively. Median overall-survival (OS) was 23.6 months with an estimated 3-year survival rate of ~30%. Cryoablation remained cost effective with or without the presence of systemic therapies, with an adjunctive cost-effectiveness ratio (ACER) of $39,661–$85,580 per LYG.

Conclusions

Multi-site cryoablation had very low complication and local recurrence rates, and was able to provide local control even for diverse soft tissue locations. Even as an adjunct to systemic therapies, MCA appeared cost-effective, with apparent increased survival.

Autor:innen und Institutionen

  • Wayne State University, Detroit, MI 48201, USA ; Department of Radiology, Wayne State University, 22473 Milner Street, St. Clair Shores, MI 48081, USA.
  • Karmanos Cancer Center, Detroit, MI 48201, USA.
  • Wayne State University, Detroit, MI 48201, USA.

Förderung

  • NCI NIH HHS

Zitieren

APA

Bang, H. J., Littrup, P. J., Currier, B. P., Goodrich, D. J., Choi, M., Heilbrun, L. K., & Goodman, A. C. (2012). Percutaneous Cryoablation of Metastatic Lesions from Colorectal Cancer: Efficacy and Feasibility with Survival and Cost-Effectiveness Observations. ISRN Minimally Invasive Surgery. https://doi.org/10.5402/2012/942364

Vancouver

Bang HJ, Littrup PJ, Currier BP, Goodrich DJ, Choi M, Heilbrun LK, et al. Percutaneous Cryoablation of Metastatic Lesions from Colorectal Cancer: Efficacy and Feasibility with Survival and Cost-Effectiveness Observations. ISRN Minimally Invasive Surgery. 2012. doi:10.5402/2012/942364

BibTeX
@article{Bang2012,
  author = {Bang, Hyun J and Littrup, Peter J and Currier, Brandt P and Goodrich, Dylan J and Choi, Minsig and Heilbrun, Lance K and Goodman, Allen C},
  title = {Percutaneous Cryoablation of Metastatic Lesions from Colorectal Cancer: Efficacy and Feasibility with Survival and Cost-Effectiveness Observations},
  journal = {ISRN Minimally Invasive Surgery},
  year = {2012},
  doi = {10.5402/2012/942364}
}
Kostenlos starten →